Form4insider filings, from the source

SEC Form 4 · accession 0000905718-17-000172

Kindred Biosciences, Inc. · KIN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 1, 2017
Accepted (ET)
Feb 3, 2017 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561743

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Equity SwapF2,F1,F3—Feb 1, 2017J30,000AFeb 1, 2017Jun 4, 2018Common Stock, $.0001 par value per share30,00030,000I

Explanation of responses